pepmg_

Study summary · research use only

Effect of intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviours in rats

Observational · animal · The international journal of neuropsychopharmacology · 2005 · DOI 10.1017/S1461145704004596 · PMID 15383157

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

In this rat study, the authors examined intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviour in the elevated plus-maze. Compared with saline controls, chronic ALCAR at 10 and 100 mg/kg (tested 24 h after the last dose) showed no effect, whereas 50 and 75 mg/kg were associated with reduced anxiety-like behaviour; acute ALCAR (100 mg/kg, tested 6 h after) was associated with anxiogenic effects. The authors suggest chronic ALCAR may produce an inverted U-shaped dose-response curve for anxiety-like behaviour and note the mechanism after peripheral administration remains undetermined.

Abstract

Acetyl-L-carnitine (ALCAR) is an acetyl derivative of carnitine, an endogenous molecule synthesized in vivo and supplemented by diet (mainly via meat and dairy products). Several parallel, double-blind, placebo-controlled studies have demonstrated that ALCAR treatment produces beneficial effects in geriatric depression. Since most antidepressants also have anti-anxiety effects we examined whether ALCAR shows anti-anxiety effects in a rat model of anxiety. Compared to a saline-injected control group, chronic administration of ALCAR at doses of 10 and 100 mg/kg (tested 24 h after the last dose administration) showed no effects, whereas doses of 50 and 75 mg/kg significantly reduced anxiety-like behaviours in the elevated plus-maze. Acute ALCAR (100 mg/kg), on the other hand (tested 6 h after administration), demonstrated anxiogenic effects. Our data suggest that chronic ALCAR administration may produce an inverted U-shaped curve of dose-dependent changes in anxiety-like behaviour. The precise mechanism by which ALCAR decreases anxiety-like behaviour after peripheral administration remains to be determined.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.